Overview

To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules

Status:
Completed
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
- Assess the rate and extent of absorption of hydrocodone from a 20 mg HC-ER capsule in both fed and fasted states - Evaluate the safety and tolerability of the test compound administered orally
Phase:
Phase 1
Details
Lead Sponsor:
Zogenix, Inc.
Treatments:
Hydrocodone